Back

GLP-1 receptor agonist use and long-term outcomes in hypertrophic cardiomyopathy with obstructive sleep apnoea: A real-world cohort analysis

30 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Hypertrophic cardiomyopathy: disease burden, risk stratification, and clinical outcomes Hypertrophic Cardiomyopathy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Susan Keen

Cleveland Clinic, Cleveland (United States of America)

6 More presentations in this session

Presentation thumbnail
Longitudinal burden of disease in hypertrophic cardiomyopathy: one-year follow-up of the AFFECT-HCM study
Miss R. Mangal (Rotterdam, NL)
Abstract
Presentation thumbnail
Real-world clinical burden of obstructive hypertrophic cardiomyopathy: a nationwide study in france
Professor A. Hagege (Paris, FR)
Abstract
Presentation thumbnail
Simplified versus complete selvester QRS scoring system for scar assessment in hypertrophic cardiomyopathy patients
Doctor N. Charoenpoonsiri (Bangkok, TH)
Abstract
Presentation thumbnail
Continuous ambulatory ECG monitoring of up to 14 days increases detection of high-risk ventricular tachyarrhythmias compared with the first 48 hours in hypertrophic cardiomyopathy
Doctor M. Maron (Burlington, US)
Abstract
Presentation thumbnail
HCM in the modern era: low mortality and predominantly predictable sudden cardiac death under systematic risk stratification
Doctor E. Karvouni (Athens, GR)
Abstract

Access the full session

Session thumbnail
Hypertrophic cardiomyopathy: disease burden, risk stratification, and clinical outcomes

The Event

Event poster

ESC Congress 2026

30 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
GLP-1-ra and heart failure-related outcomes in patients with and without a history of heart failure: a systematic review and meta-analysis.
23 May 2023
thumbnail
Congress Presentation
Outcomes in hypertrophic obstructive cardiomyopathy patients undergoing non-cardiac surgery-a nationwide analysis
29 August 2022
thumbnail
Congress Presentation
The association of LEPR rs1137101 polymorphism with the incidence of left ventricular hypertrophy in patients with obstructive sleep apnea and hypertension.
2 September 2019
thumbnail
Congress Presentation
Impact of GLP-1 and dual agonists on the incidence of new cases of physician-reported sleep apnoea: A real-world propensity score-matched study
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources